secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearSign Technologies Corp (CLIR)
CIK:        0001434524
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001104659-24-086124
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearSign appoints G. Todd Silva to board of directors effective August 1, 2024
-------------------------------------------------------------------------------

- Mr. Silva, nominated by clirSPV LLC, fills vacancy created by Robert T. Hoffman, Sr.'s June 2024 resignation.
- He brings over 30 years of leadership and finance experience; currently CFO of Radiance Therapeutics.
- Mr. Silva will receive quarterly RSU grants of $15,000 under the 2021 Equity Incentive Plan.
- Initial RSU grant pro-rated for the portion of Q3 2024 served on the board.
- Appointment effective August 1, 2024; no other arrangements or family relationships disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434524/000110465924086124/0001104659-24-086124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434524/000110465924086124/tm2420801d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-086124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer